Developing Targeted Therapies to Treat Brain Cancer
In the United States, nearly 24,000 people are estimated to receive a brain or nervous system cancer diagnosis in 2020....
In the United States, nearly 24,000 people are estimated to receive a brain or nervous system cancer diagnosis in 2020....
“The field of cell therapy is one of the most exciting fields in translational medicine,” began Katayoun Rezvani, MD, PhD,...
Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United...
A study finds that the rate of death from opioids was 10 times lower in cancer patients than in...
Over the past decade, immune checkpoint inhibitors have transformed cancer care for a variety of tumor types. This form of immunotherapy can lead to long-lasting...
Researchers present new data on cancer biology, treatment, screening and risk reduction at the AACR Virtual Annual Meeting I.
At the AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer...
Early detection of most cancers is an elusive and daunting task; nevertheless, it has remained a top priority for...
Researchers from around the globe share insights into cancer and the coronavirus at the AACR Virtual Annual Meeting I.
The cutting-edge scientific program for the AACR Virtual Annual Meeting I began Monday, April 27, with an Opening Clinical Plenary featuring...